DK1233763T3 - Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling - Google Patents

Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling

Info

Publication number
DK1233763T3
DK1233763T3 DK00985090T DK00985090T DK1233763T3 DK 1233763 T3 DK1233763 T3 DK 1233763T3 DK 00985090 T DK00985090 T DK 00985090T DK 00985090 T DK00985090 T DK 00985090T DK 1233763 T3 DK1233763 T3 DK 1233763T3
Authority
DK
Denmark
Prior art keywords
preparation
improved stability
transdermal therapeutic
therapeutic systems
systems
Prior art date
Application number
DK00985090T
Other languages
English (en)
Inventor
Walter Mueller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007565&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1233763(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10054713A external-priority patent/DE10054713C2/de
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Application granted granted Critical
Publication of DK1233763T3 publication Critical patent/DK1233763T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
DK00985090T 1999-11-29 2000-11-24 Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling DK1233763T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19957401 1999-11-29
DE10054713A DE10054713C2 (de) 1999-11-29 2000-11-04 Transdermale Therapeutische Systeme mit verbesserter Stabilität und ein Verfahren zu ihrer Herstellung
PCT/EP2000/011692 WO2001039753A1 (de) 1999-11-29 2000-11-24 Transdermale therapeutische systeme mit verbesserter stabilität und ein verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DK1233763T3 true DK1233763T3 (da) 2003-10-20

Family

ID=26007565

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985090T DK1233763T3 (da) 1999-11-29 2000-11-24 Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling

Country Status (21)

Country Link
US (1) US6699498B1 (da)
EP (1) EP1233763B1 (da)
JP (1) JP5753645B2 (da)
CN (1) CN1195506C (da)
AR (1) AR026621A1 (da)
AT (1) ATE245972T1 (da)
AU (1) AU779523B2 (da)
BR (1) BRPI0015939B8 (da)
CA (1) CA2396686C (da)
CZ (1) CZ295031B6 (da)
DK (1) DK1233763T3 (da)
ES (1) ES2204732T3 (da)
HU (1) HU228822B1 (da)
IL (1) IL149812A0 (da)
MX (1) MXPA02005292A (da)
NZ (1) NZ519069A (da)
PL (1) PL198323B1 (da)
PT (1) PT1233763E (da)
RU (1) RU2266735C2 (da)
TW (1) TWI272108B (da)
WO (1) WO2001039753A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
US20030027793A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal treatment of parkinson's disease
US20030026830A1 (en) * 2001-05-08 2003-02-06 Thomas Lauterback Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine
US20060263419A1 (en) * 2002-03-12 2006-11-23 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
US20060216336A1 (en) * 2002-05-07 2006-09-28 Hans-Michael Wolff Transdermal therapeutic system for Parkinson's Disease
DE10224612A1 (de) * 2002-06-04 2003-12-24 Lohmann Therapie Syst Lts Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
US8211462B2 (en) * 2002-07-30 2012-07-03 Ucb Pharma Gmbh Hot-melt TTS for administering rotigotine
US8246979B2 (en) 2002-07-30 2012-08-21 Ucb Pharma Gmbh Transdermal delivery system for the administration of rotigotine
SI1426049T1 (en) * 2002-12-02 2005-08-31 Sanol Arznei Schwarz Gmbh Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
TW200514582A (en) * 2003-10-31 2005-05-01 Hisamitsu Pharmaceutical Co Transdermal preparation and method for reducing side effect in pergolide therapy
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
WO2020250840A1 (ja) * 2019-06-14 2020-12-17 久光製薬株式会社 ロチゴチン含有貼付剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56103117A (en) * 1980-01-19 1981-08-18 Nitto Electric Ind Co Ltd Stabilized plaster containing drug
JPS60199832A (ja) * 1984-03-22 1985-10-09 Nitto Electric Ind Co Ltd 抗酸化性外用製剤
FR2619388A1 (fr) 1987-08-14 1989-02-17 Rhone Poulenc Chimie Article stratifie souple pour adhesif de transfert
JPH01249885A (ja) * 1988-03-30 1989-10-05 Narisu Keshohin:Kk 脂質の酸化防止剤
JP2788754B2 (ja) * 1989-05-12 1998-08-20 日東電工株式会社 シート状経皮吸収デバイス
JPH03232817A (ja) * 1990-02-07 1991-10-16 Showa Yakuhin Kako Kk 貼付剤
IE82916B1 (en) * 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
JP2869167B2 (ja) * 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JP3723229B2 (ja) * 1991-03-12 2005-12-07 武田薬品工業株式会社 外用貼付剤
JP3034077B2 (ja) * 1991-04-19 2000-04-17 久光製薬株式会社 メラニン抑制貼付剤
JPH05306227A (ja) * 1992-04-27 1993-11-19 Lion Corp 徐放性口腔内疾患治療剤
JPH0624969A (ja) * 1992-07-09 1994-02-01 Teikoku Seiyaku Co Ltd ケトプロフェン含有外用貼付剤
DE4224325C1 (de) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Wirkstoffpflaster für niedrigschmelzende und/oder flüchtige Wirkstoffe und Verfahren zu seiner Herstellung
DE4336557C2 (de) * 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
IL109539A0 (en) 1994-05-03 1994-08-26 Yissum Res Dev Co Substained-release pharmaceutical system for the delivery of antioxidants
JP3157082B2 (ja) * 1994-09-22 2001-04-16 昭和薬品化工株式会社 医療用パック型製剤用基剤および医療用パック型製剤
JP3117619B2 (ja) * 1995-06-07 2000-12-18 花王株式会社 （メタ）アクリル酸系（共）重合体の製造方法
JP3361674B2 (ja) * 1995-11-08 2003-01-07 日本カーバイド工業株式会社 医療用粘着剤組成物
FR2744368B1 (fr) * 1996-02-02 1998-04-24 Fabre Pierre Dermo Cosmetique Composition dermocosmetique contenant du retinal
DE19700913C2 (de) * 1997-01-14 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Hormonen
US6017950A (en) * 1997-08-05 2000-01-25 Millennium Pharmaceuticals, Inc. Methods for controlling gram negative bacteria in mammals
GB9800526D0 (en) * 1998-01-12 1998-03-11 Ciba Geigy Ag Organic compounds
DE19814084B4 (de) * 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
JP4275768B2 (ja) * 1998-06-18 2009-06-10 久光製薬株式会社 水性粘着膏体

Also Published As

Publication number Publication date
US6699498B1 (en) 2004-03-02
BR0015939B1 (pt) 2013-10-08
NZ519069A (en) 2004-06-25
HUP0203318A3 (en) 2004-06-28
PT1233763E (pt) 2003-11-28
PL355606A1 (en) 2004-05-04
CN1195506C (zh) 2005-04-06
IL149812A0 (en) 2002-11-10
CZ295031B6 (cs) 2005-05-18
AU2162301A (en) 2001-06-12
CA2396686A1 (en) 2001-06-07
CZ20021867A3 (cs) 2002-11-13
HUP0203318A2 (hu) 2003-02-28
BRPI0015939B8 (pt) 2021-05-25
WO2001039753A1 (de) 2001-06-07
JP5753645B2 (ja) 2015-07-22
PL198323B1 (pl) 2008-06-30
EP1233763B1 (de) 2003-07-30
ATE245972T1 (de) 2003-08-15
AR026621A1 (es) 2003-02-19
RU2266735C2 (ru) 2005-12-27
EP1233763A1 (de) 2002-08-28
JP2003515554A (ja) 2003-05-07
CA2396686C (en) 2008-07-08
TWI272108B (en) 2007-02-01
ES2204732T3 (es) 2004-05-01
RU2002118325A (ru) 2004-02-20
AU779523B2 (en) 2005-01-27
MXPA02005292A (es) 2002-12-11
CN1402633A (zh) 2003-03-12
HU228822B1 (en) 2013-05-28
BR0015939A (pt) 2002-08-20

Similar Documents

Publication Publication Date Title
DK1233763T3 (da) Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DK0750907T3 (da) Stabile vaccinepræparater til parenteral administrering, en fremgangsmåde til deres anvendelse og en fremgangsmåde til deres fremstilling
DK1538160T3 (da) Substituerede isochinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO995063L (no) Preparat med forsinket frigjöring og fremgangsmåter for deres fremstilling
NO20015156L (no) 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse
NO20000627L (no) Forhåndsbelagte gjødningsmidler med kontrollert frigjøring og fremgangsmåter for deres fremstilling
NO20002486D0 (no) Sykliske aminderivater og deres anvendelse som legemidler
NO20014603D0 (no) Tienopyrimidinforbindelser, deres fremstilling og anvendelse
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
DK1242012T3 (da) Forbedret transdermalt præventionsmiddelafgivelsessystem og fremgangsmåde
DK1164996T3 (da) Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK0903339T3 (da) Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament
ATE310510T1 (de) Transdermales therapeutisches system zur abgabe von lerisetron
NO20030547D0 (no) Azabicykliske derivater og deres terapeutiske anvendelse
DK1086077T3 (da) Hidtil ukendte antiestrogener, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse
DK1261625T3 (da) Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
NO20020404D0 (no) Streptograminderivater, deres produksjon og forbindelser derav
DK0973760T3 (da) Kodaistatiner A, B, C og D, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20022482D0 (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav